RBR-6kkmskk尚未招募未知
Safety and efficacy in the treatment of primary open-angle glaucoma with Triplenex compared to isolated medications
centro oftalmologico de minas gerais0 个研究点开始时间: 2021年6月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 17Y 至 0（—）
入选标准
- •18 years of age minimum; ocular hypertension with intraocular pressure levels greater than or equal to 21 mmHg; carrier of open angle glaucoma presenting intraocular pressure levels greater than or equal to 18 mmHg; reduction of intraocular pressure in relation to baseline values ??<30%; patients intolerant of current treatment due to ocular surface symptoms; meet the criteria of the control group for at least 3 months;
排除标准
- •monoaminoxidase users; patients with asthma or severe chronic obstructive pulmonary disease; patients with sinus bradycardia, atrioventricular block of 2 or 3 degrees not controlled with a pacemaker, decompensated congestive heart failure; patient known to be allergic to any of the components of TRIPLENEX; pregnant patients; patients with any corneal irregularity that hinder the perfect reading of intraocular pressure by Goldman's tonometer (intra stromal ring, corneal transplant or scars with important corneal thinning); patients undergoing anti-glaucoma surgical procedures in the last 3 months (laser trabeculoplasty; incisional procedures such as trabeculectomy; glaucoma drainage devices, among others)
研究者
相似试验
招募中
2 期
Safety of different doses of the antimalarial drug Primaquine on Vivax Malaria Treatment in patients Deficient of the enzyme Glucose-6-phospate DehydrogenaseAnemia due to glucose-6-phospate dehydrogenase deficiencymalaria by Plasmodium vivaxB51.8D55.0RBR-2rcm2gFundação de Medicina Tropical Heitor Vieira Dourado - FMTHVD
招募中
Unknown
Efficacy and safety of initial treatment (combination immunotherapy or chemotherapy + ICI) in advanced non-small cell lung cancer patients (TPS 1-49%): A multicenter retrospective observational study (TOPGAN2023-01)non small cell carcinomaJPRN-UMIN000052228department of respiratory medicine hirosaki university graduate school of medicine300
已完成
4 期
Efficacy and safety of regular treatment with procaterol and budesonide inhalation suspension for young children with moderate persistent asthma.Bronchial AsthmaJPRN-UMIN000003492niversity of Toyama, Faculty of Medicine, Department of Pediatrics50
已完成
2 期
Efficacy and feasibility of first-line treatment with risk-adapted dose-adjusted EPOCH-R (DA-EPOCH-R) in patients with Burkitt lymphoma. A phase II clinical trial.Burkitt lymphomahighly aggressive B cell lymphoma10025320NL-OMON36941Vrije Universiteit Medisch Centrum22
进行中（未招募）
不适用
A trial to investigate treatment with EPOCH-R in patients with Burkitt lymphoma, by adapting the dose to the risk classification of the disease.Burkitt lymphomaMedDRA version: 14.1Level: HLTClassification code 10006596Term: Burkitt's lymphomasSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2012-003141-16-NLVU University Medical Center